Jackson Grant Investment Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$56.8K	Hold	500	–	–	0.02%	174
2025 Q1	$52.6K	Hold	500	–	–	0.02%	173
2024 Q4	$53.6K	Hold	500	–	–	0.02%	174
2024 Q3	$50K	Hold	500	–	–	0.02%	181
2024 Q2	$42.1K	Hold	500	–	–	0.02%	191
2024 Q1	$36.6K	Hold	500	–	–	0.02%	190
2023 Q4	$35.7K	Hold	500	–	–	0.02%	191
2023 Q3	$30K	Hold	500	–	–	0.01%	201
2023 Q2	$36.1K	Hold	500	–	–	0.02%	188
2023 Q1	$36.8K	Hold	500	–	–	0.02%	205
2022 Q4	$33.4K	Sell	500 -302	-38%	-$20.2K	0.02%	213
2022 Q3	$43K	Hold	802	–	–	0.02%	185
2022 Q2	$45K	Hold	802	–	–	0.02%	191
2022 Q1	$56K	Hold	802	–	–	0.02%	187
2021 Q4	$77K	Hold	802	–	–	0.04%	138
2021 Q3	$70K	Hold	802	–	–	0.03%	177
2021 Q2	$66K	Hold	802	–	–	0.03%	176
2021 Q1	$76K	Hold	802	–	–	0.04%	165
2020 Q4	$50K	Hold	802	–	–	0.03%	184
2020 Q3	$48K	Hold	802	–	–	0.03%	149
2020 Q2	$56K	Hold	802	–	–	0.04%	136
2020 Q1	$36K	Hold	802	–	–	0.03%	151
2019 Q4	$52K	Hold	802	–	–	0.03%	147
2019 Q3	$50K	Hold	802	–	–	0.03%	148
2019 Q2	$57K	Hold	802	–	–	0.03%	141
2019 Q1	$63K	Hold	802	–	–	0.04%	134
2018 Q4	$68K	Hold	802	–	–	0.05%	130
2018 Q3	$137K	Buy	+802	New	+$137K	0.09%	102